Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,055
datasets available to search
ShareScore release 0.9.0
Dataset results
1,055 results for “insomnia”
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
ClinicalTrials.gov study NCT00318448. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions
ClinicalTrials.gov study NCT01955928. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cognitive Behavioral Therapy for Insomnia with RTMS
ClinicalTrials.gov study NCT04258618. IPD Sharing: NO. Countries: 1. Publications: 1.
Treating Insomnia in Mild Cognitive Impairment
ClinicalTrials.gov study NCT06687161. IPD Sharing: YES. Countries: 1. Publications: 0.
Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study
ClinicalTrials.gov study NCT04253691. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05866887. IPD Sharing: YES. Countries: 1. Publications: 0.
Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors
ClinicalTrials.gov study NCT03279055. IPD Sharing: NO. Countries: 1. Publications: 1.
A Pragmatic Pilot Study of Cognitive Behavioural Therapy for Insomnia Among People Living With HIV
ClinicalTrials.gov study NCT02887209. IPD Sharing: NO. Countries: 1. Publications: 9.
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
ClinicalTrials.gov study NCT00492011. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients
ClinicalTrials.gov study NCT05277038. IPD Sharing: NO. Countries: 1. Publications: 1.
Data from: A 45-year-old man with progressive insomnia, psychiatric and motor symptoms
Open the record for dataset details and reuse information.
Chronic insomnia and bed partner actigraphy data
Open the record for dataset details and reuse information.
Data from: Hypothalamic circuitry underlying stress-induced insomnia and peripheral immunosuppression
Open the record for dataset details and reuse information.
Data from: Daridorexant, a new dual orexin receptor antagonist in elderly subjects with insomnia disorder: a randomized clinical trial
<p><b>Objective:</b> To assess the dose-response of daridorexant, a new dual orexin receptor antagonist, on wake after sleep onset (WASO).</p> <p><b>Methods:</b> Elderly (≥65 years) subjects (n = 58) with insomnia were randomly allocated (Latin square design) to receive five treatments (5, 10, 25, and 50 mg daridorexant and placebo) during five treatment periods, each consisting of two treatment nights followed by a 5–12-day washout period. Main efficacy endpoints were the absolute change from baseline in WASO (primary) and latency to persistent sleep (LPS; secondary) to Days 1&2 (mean of two treatment nights assessed by polysomnography) in each period. Safety and tolerability were also assessed.</p> <p><b>Results:</b> Of 58 subjects included, 67% were female and median age was 69 years [range 65–85]). WASO and LPS were dose-dependently reduced from baseline to Days 1&2 following daridorexant administration (multiple comparison procedure-modeling, p<0.0001 and p=0.004, respectively); reductions were statistically significant for doses 10 mg and above compared with placebo (WASO: –32.0, –45.1, –61.4 min; LPS: –44.9, –43.8, –45.4 min; for 10, 25, and 50 mg, respectively, p≤0.025). Treatment-emergent adverse events were similar for daridorexant and placebo; the most frequent were fatigue, nasopharyngitis, gait disturbance, and headache (≤7% in any group).</p> <p><b>Conclusions:</b> Daridorexant was well tolerated. Dose-dependent improvements in WASO and LPS were statistically significant (dose range 10–50 mg) in elderly subjects with insomnia disorder. ClinicalTrials.gov (NCT02841709).</p> <p><b>Classification of Evidence:</b> This study provides Class III evidence that for elderly subjects with insomnia, daridorexant reduced wake after sleep onset time.</p>
Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0
ClinicalTrials.gov study NCT07216261. IPD Sharing: YES. Countries: 1. Publications: 0.
The Psychoneuroimmunology of Insomnia
ClinicalTrials.gov study NCT00680771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
ClinicalTrials.gov study NCT02669082. IPD Sharing: YES. Countries: 1. Publications: 0.
A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
ClinicalTrials.gov study NCT02729714. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care
ClinicalTrials.gov study NCT04565223. IPD Sharing: NO. Countries: 0. Publications: 1.
Effect of Different Foot Baths on Postpartum Insomnia and Fatigue
ClinicalTrials.gov study NCT07060755. IPD Sharing: NO. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.